Evaluation of the Disk Diffusion Test for Bacteroides fragilis Group Clinical Isolates
- PMID: 39344145
- PMCID: PMC11609709
- DOI: 10.3343/alm.2024.0159
Evaluation of the Disk Diffusion Test for Bacteroides fragilis Group Clinical Isolates
Abstract
Background: Bacteroides fragilis group (BFG) isolates are the most frequently isolated gram-negative anaerobic bacteria and exhibit higher levels of antimicrobial resistance than other anaerobic bacteria. Reliable susceptibility testing is needed because of reports of resistance to the most active antibiotics. Recently, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) introduced disk zone diameter breakpoints. We evaluated the disk diffusion test (DDT) for susceptibility testing of BFG isolates compared with the agar dilution method.
Methods: In total, 150 BFG isolates were collected from three institutes in Korea. The agar dilution method was conducted according to the CLSI guidelines. DDT was performed following the EUCAST guideline. Fastidious anaerobe agar supplemented with 5% defibrinated horse blood was used as the culture medium. Nine antimicrobials were evaluated: penicillin, cefoxitin, cefotetan, imipenem, meropenem, piperacillin-tazobactam, clindamycin, moxifloxacin, and metronidazole.
Results: The categorical agreement (CA) between the two methods was >90.0% for imipenem, meropenem, clindamycin, and metronidazole. However, the CA for piperacillintazobactam was low, at 83.2%. Major errors were found: 5.4% for imipenem, 7.4% for meropenem, and 12.8% for piperacillin-tazobactam. All minor errors were <10%. We propose using the area of technical uncertainty (ATU) zone-overlapping area for susceptible and resistant strains to reduce errors in the DDT. Outside the ATU, the CAs of cefoxitin, cefotetan, and piperacillin-tazobactam were >90.0%, whereas that of moxifloxacin was increased to 88.5%.
Conclusions: The DDT can be a useful alternative antimicrobial susceptibility test for BFG isolates when using the ATU zone to reduce errors.
Keywords:
Area of technical uncertainty;
Conflict of interest statement
None declared.
Figures


Similar articles
-
Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.Anaerobe. 2015 Feb;31:65-71. doi: 10.1016/j.anaerobe.2014.10.008. Epub 2014 Nov 11. Anaerobe. 2015. PMID: 25464140
-
Antimicrobial susceptibility testing of Bacteroides species by disk diffusion: The NordicAST Bacteroides study.Anaerobe. 2023 Jun;81:102743. doi: 10.1016/j.anaerobe.2023.102743. Epub 2023 May 28. Anaerobe. 2023. PMID: 37253399
-
Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021.Anaerobe. 2023 Aug;82:102756. doi: 10.1016/j.anaerobe.2023.102756. Epub 2023 Jul 8. Anaerobe. 2023. PMID: 37429411
-
Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.Ann Lab Med. 2015 Jan;35(1):94-8. doi: 10.3343/alm.2015.35.1.94. Epub 2014 Dec 8. Ann Lab Med. 2015. PMID: 25553287 Free PMC article.
-
Time for Some Group Therapy: Update on Identification, Antimicrobial Resistance, Taxonomy, and Clinical Significance of the Bacteroides fragilis Group.J Clin Microbiol. 2022 Sep 21;60(9):e0236120. doi: 10.1128/jcm.02361-20. Epub 2022 Jun 14. J Clin Microbiol. 2022. PMID: 35700139 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous